This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Hancock Whitney (HWC) Beats Q4 Earnings Estimates
by Zacks Equity Research
Hancock Whitney (HWC) delivered earnings and revenue surprises of 1.23% and 3.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Build-A-Bear Workshop and Bally's have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Build-A-Bear Workshop and Bally's are part of the Zacks Bull and Bear of the Day article.
Higher Rates, Robust Trading to Aid Schwab's (SCHW) Q4 Earnings
by Zacks Equity Research
Schwab (SCHW) is expected to have witnessed a robust trading performance in the fourth quarter of 2022. Driven by higher rates, its interest income is expected to have risen.
Higher Rates, Loan Growth to Aid Truist's (TFC) Q4 Earnings
by Zacks Equity Research
Truist (TFC) is expected to have recorded an improvement in its interest income in the fourth quarter of 2022, given the rise in interest rates and loan growth.
Trading, NII to Aid Goldman's (GS) Q4 Earnings, IB to Hurt
by Zacks Equity Research
Robust trading and higher interest rates are expected to have aided Goldman's (GS) Q4 earnings amid weakness in IB business.
Washington Federal (WAFD) Q1 Earnings Beat, Revenues Rise
by Zacks Equity Research
Washington Federal's (WAFD) fiscal Q1 earnings benefits from improvement in revenues, increasing loan balances and higher rates. However, rise in expenses and provisions are headwinds.
BofA (BAC) Q4 Earnings Beat Estimates on Solid Trading & NII
by Zacks Equity Research
Bank of America (BAC) records a rise in revenues in the fourth quarter of 2022. Higher expenses hurt results to some extent.
BNY Mellon's (BK) Q4 Earnings Beat Despite Lower Revenues
by Zacks Equity Research
BNY Mellon (BK) records a decline in revenues and higher expenses in the fourth quarter of 2022.
Hancock Whitney (HWC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Hancock Whitney (HWC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Higher Rates, Loan Growth to Aid BNY Mellon's (BK) Q4 Earnings
by Zacks Equity Research
BNY Mellon's (BK) interest income is expected to have increased in the fourth quarter of 2022, supported by loan growth and higher interest rates.
AUM Growth Likely to Support BlackRock (BLK) in Q4 Earnings
by Zacks Equity Research
BlackRock (BLK) is expected to have witnessed AUM growth in the fourth quarter of 2022.
Is Hancock Whitney (HWC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Synchrony (SYF) Up 16% in 6 Months: More Room to Run?
by Zacks Equity Research
Synchrony (SYF) is well-poised to gain on several growth initiatives, a strong CareCredit platform and prudent capital deployment efforts.
Bet on These 5 Low Leverage Stocks to Avoid Inflation Woes
by Aparajita Dutta
In times of crisis, a prudent investor always looks for stocks that are safe bets instead of looking at only high-growth value companies. You may buy MTG, TA, HWC, CLDT & KNSL.
East West Bancorp (EWBC) Rides on High Rates as Asset Quality Ails
by Zacks Equity Research
Solid loans and deposit balances, a strong balance sheet and higher interest rates support East West Bancorp (EWBC) amid mounting expenses and worsening asset quality.
3 Bank Stocks Wall Street Analysts Recommend for 2023
by Swayta Shah
Analyst-recommended bank stocks - Wells Fargo (WFC), Citizens Financial (CFG) and Hancock Whitney (HWC) - can be considered for 2023 on solid prospects despite near-term headwinds.
After Plunging 6.7% in 4 Weeks, Here's Why the Trend Might Reverse for Hancock Whitney (HWC)
by Zacks Equity Research
Hancock Whitney (HWC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Signature Bank (SBNY) to Reduce Crypto Exposure by $8-$10B
by Zacks Equity Research
Signature Bank (SBNY) is likely to reduce deposits tied to cryptocurrencies by $8 billion to $10 billion and eventually reduce digital asset-related deposit exposure to less than 15%.
Should Value Investors Buy Hancock Whitney (HWC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
6 Reasons Why Hancock Whitney (HWC) is an Attractive Pick Now
by Zacks Equity Research
Supported by strong fundamentals and solid earnings and sales growth projections, Hancock Whitney (HWC) stock seems to be a good investment option now.
Here's Why You Should Hold on to Navient (NAVI) Stock Now
by Zacks Equity Research
Growth in student loan refinancing volumes and private loan originations will aid Navient's (NAVI). However, higher expenses and limited liquidity remain concerning.
4 Reasons to Invest in Webster Financial (WBS) Stock Now
by Zacks Equity Research
Webster Financial (WBS) seems to be a promising bet now, driven by strong fundamentals and impressive acquisition-driven growth momentum.
Active Equity Focus, Robust AUM Aid BlackRock (BLK), Costs Ail
by Zacks Equity Research
Continued rise in expenses might hurt BlackRock's (BLK) bottom-line growth. However, efforts to restructure the active equity business will likely aid the top line.
5 Reasons Why Cullen/Frost (CFR) Stock is Worth Buying Now
by Zacks Equity Research
Expansion in strategic markets, higher interest rates and a robust balance sheet are set to keep supporting Cullen/Frost (CFR) in the near term, making it an attractive investment option.
Associated Banc-Corp (ASB) Rides on Rates, Faces Cost Woes
by Zacks Equity Research
Strategic expansion, business restructuring efforts, rising rates and robust loan balances are likely to aid Associated Banc-Corp's (ASB) financials. Mounting expenses and high commercial loan exposure are concerns.